Future studies may reveal that therapeutics targeting localized hyperosmotic adaptation could represent a novel class of medicines for the treatment of many disorders
Future studies may reveal that therapeutics targeting localized hyperosmotic adaptation could represent a novel class of medicines for the treatment of many disorders. both BGT1 and the only Fosfructose trisodium enzyme that can metabolize betaine, namely betaine:homocysteine CS-methyltransferase (BHMT1). The BHMT1 enzyme removes a methyl group from betaine and transfers it to homocysteine, a potential…